SUMMARY -Some manufacturers do not provide automated intracardiac electrogram method (IEGM) systems for atrioventricular (AV) and interventricular (VV) delay optimization in cardiac resynchronization therapy (CRT). We aimed to evaluate the accuracy of manual IEGM method in 48 patients previously implanted with Medtronic Syncra CRT. All patients underwent standard device interrogation followed by CRT optimization by IEGM method and by echocardiography one month after implantation. Th e patient mean age was 60.7±11.8 years and there were 33 (68.8%) males. After CRT implantation, the left ventricular ejection fraction increased from 28.0±7.9% to 39.1±11.0% (p<0.001). Optimal aortic fl ow Velocity Time Integral (aVTI) was obtained when VV was set to 20-50 ms left ventricular pre-activation. Th ere was a strong correlation between VV values determined by echocardiography and IEGM (R=0.823, p<0.001). We found no signifi cant diff erence in AV, VV and aVTI values between echocardiography and IEGM method. However, IEGM was signifi cantly less time-consuming than echocardiography [20 (10-28) vs. 40 (35-60) minutes, p<0.001]. Manual IEGM method may be good alternative to echocardiography and automated IEGM method. It also emphasizes the need for implementation of automated IEGM systems in as many CRT devices as possible.
Introduction
In refractory congestive heart failure (CHF) accompanied by left bundle branch block (LBBB), cardiac resynchronization therapy (CRT) with biventricular pacing has been shown to be associated with better outcomes and has been established as an adjunctive heart failure treatment [1] [2] [3] . It has been shown in multicenter studies that CRT reduces mortality, and improves exercise tolerance and quality of life [4] [5] [6] . Sequential ventricular pacing can increase mechanical effi ciency, decrease delay in contraction between adjacent left ventricular (LV) walls, reduce mitral regurgitation 7, 8 , and increase ejection fraction (EF). However, up to 30% of patients who underwent CRT implantation show no improvement. Th e reasons for failure to respond include suboptimal lead placement, device programming and/or patient selection. Atrioventricular (AV) delay also has a signifi cant eff ect on the hemodynamic performance of cardiac pacing since insuffi cient LV fi lling in diastole leads to a decline in cardiac output 9 . Optimizing the third parameter of dyssynchrony, the interventricular (VV) delay, with se-quential biventricular pacing compared to simultaneous biventricular pacing has also been shown to incrementally improve cardiac function [7] [8] [9] [10] [11] [12] . AV/PV and VV delay optimization is not commonly performed in routine clinical practice despite being one of the programmable parameters available. Only those that do not show improvement from CRT undergo echocardiographic optimization of their AV and VV intervals due to the costs, time constraints, and skill and expertise required to perform accurately.
Th e intracardiac electrogram method (IEGM) has been designed to calculate optimal AV/PV and VV delays during routine device follow-up 1 . Several studies have reported diagnostic accuracy of IEGM performed by using the software provided along with St. Jude's devices 1, 13, 14 . Such automated IEGM yielded similar results as echocardiography for AV and VV optimization. However, some CRT device manufacturers do not provide automated IEGM systems for AV and VV optimization.
Th e aim of this study was to evaluate diagnostic accuracy of manual application of IEGM formula used by St. Jude's devices in patients undergoing CRT with Medtronic devices and to evaluate whether the IEGM of AV/PV and VV delay optimization would produce similar hemodynamic results as assessed by aortic VTI as a surrogate for stroke volume compared with the standard Doppler echocardiogram technique.
Patients and Methods

Patients
We included 48 patients previously implanted with Medtronic Syncra CRT-P cardiac resynchronization therapy devices. All patients at our institution who fulfi lled the standard indications for CRT according to ESC guidelines at the time of inclusion 15 were invited to participate in this prospective study, which was approved by the local research Ethics Committee. Patients were excluded from IEGM studies if they had no intrinsic atrial activity (atrial rate ≤40 bpm); had atrial fi brillation at the time of the study testing and evaluation; or were unable to provide analyzable echocardiogram images. One month after CRT implantation, all patients underwent standard device interrogation followed by optimization of the CRT pacemaker settings by IEGM and by echocardiography (ECHO). Th e study was performed during a single scheduled follow up visit. All patients were fi rst programmed, utilizing the IEGM, and after that, all patients underwent ECHO optimization. Th e investigator performing the ECHO study was blinded to the results of the IEGM evaluation.
Th e study was approved by the institutional Review Board. Considering human and animal rights, all procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.
Methods
Cardiac resynchronization therapy optimization using intracardiac electrogram method
Calculation of the optimal sensed AV interval is based on atrial intrinsic depolarization (atrial IEGM). Th e atrial IEGM (P-wave duration) represents atrial conduction time and enables estimation of mitral valve closure. Th e algorithm measures the width of the atrial IEGM, which is off -set by a factor of 30 ms if the intrinsic depolarization is >100 ms, or 60 ms if the intrinsic depolarization is <100 ms. Th e off -set enables delivery of ventricular pacing after completion of atrial mechanical contraction ensuring complete mitral valve closure and maximizing preload. Th e optimal paced AV delay is calculated as the sum of sensed AV delay and the pacing latency of 40 ms 16 . Th e IEGM VV delay calculation algorithm is based on the hypothesis that during optimal depolarization, two paced wavefronts from the RV and LV leads will meet near the interventricular septum. Th e VV delay algorithm has two components: the conduction delay (Δ) and the correction term (ε) (1). Δ represents diff erence between the time of peak intrinsic activation on the LV lead (R LV ) and the RV lead (R RV ) [Δ R LV -R RV ]. ε is diff erence in the inter-ventricular conduction delay (IVCD) between two ventricular paced propagation waveform time delays. Th e IVCD RL is the interventricular conduction delay when the RV lead is paced and the delay is sensed at the LV lead, while the IVCD LR is estimated when the LV lead is paced and the delay represents the time when the signal is sensed at the RV lead. Furthermore, each chamber is paced after a short AV delay to ensure no fusion occurs. Th e correction term equation is ε = IVCD LR -IVCD RL. Th e IEGM optimal VV delay equals 0.5 (Δ + ε). If measured VV is more than 0, the LV is activated fi rst, and if VV is less than 0, the RV is activated fi rst. Previous studies showed promise for the IEGM since the predicted optimal VV delays were linearly correlated with echocardiographic aortic VTI 1, [17] [18] [19] .
Cardiac resynchronization therapy optimization by echocardiography
Atrioventricular optimization
Optimization of the AV and VV intervals was undertaken using Pulse Wave Doppler of the General Electric Vivid 7 ultrasound machine. Th e AV interval was optimized fi rst since it has been shown to provide more hemodynamic benefi t than adjusting the VV interval 20 . Th e mitral infl ow velocity profi le was obtained in apical four-chamber view at the level of mitral valve leafl et tips at the sweep speed of 100 mm/s. First measurements were taken with either a very long (200 ms) or very short (60 ms) AV interval and the duration of the mitral infl ow velocity profi le (EA duration) was measured in expiration. Th e AV interval was then adjusted in 10 ms decrements/increments, respectively, and the EA duration was measured for each AV interval. Th e optimal AV interval was defi ned as the shortest AV interval that resulted in maximal EA duration, thus representing the longest LV fi lling time without truncating the A wave of mitral infl ow by the onset of ventricular systole 21, 22 .
Interventricular interval optimization
Th e LV outfl ow tract (LVOT) Pulse Wave Doppler velocity profi les were measured in the apical fi vechamber view at the sweep speed of 100 mm/s. Th e LVOT VTI was measured in expiration at each VV interval ranging from -40 to +40 ms in 10 ms increments. Only if the optimal LVOT VTI was measured at a VV interval of -40 or +40 ms, further measurements of LVOT VTI were performed with 10 ms increments (i.e. at -50 or +50 ms). Th e optimal VV interval was defi ned as the VV interval with highest LVOT VTI (a surrogate measure of stroke volume and cardiac output). Inter-observer variability was eliminated by ensuring all measurements were performed by a single senior echocardiographer. Intra-patient variability was 
Statistical analyses
Patient characteristics were assessed with descriptive statistics presented as mean and standard deviation or median with interquartile range values. Independent variables were compared using the MannWhitney test and Fisher exact test, as appropriate. Dependent variables were compared using the Wilcoxon test. All correlations were performed using the Spearman's correlation coeffi cient. Sample size was calculated to be 45, when considering type 1 error (a) to be 5% and type 2 error (b) to be 20%. Statistical analyses were performed using STATISTICA, ver. 6.0. Th e value of p<0.05 was considered signifi cant.
Results
Th e mean patient age was 60.7±11.8 years and there were 33 (68.8%) males. Th e remaining characteristics of the study population are presented in Table  1 . After CRT implantation, EF increased from 28.0±7.9% to 39.1±11.0%, LVEDV decreased from 241±84 mL to 189±80 mL, and LVESV decreased from 177±68 mL to 121±64 mL (p<0.001 all). Optimal aortic VTI was obtained when VV was set to 20-50 ms left ventricular pre-activation. Th e distribution of VV determined by echocardiography or IEGM was similar (Fig. 1) . Moreover, we found no signifi cant difference in sensed atrioventricular interval (SAV), paced atrioventricular interval (PAV), VTI and VV values between echocardiography and IEGM. However, IEGM was signifi cantly less time-consuming (Table 2) . Th ere was a strong correlation between VV values determined by echocardiography and IEGM (ρ=0.823, p<0.001) (Fig. 2) . We also found similar positive correlations between PAV and SAV values determined by echocardiography and IEGM, but this correlation was substantially weaker (ρ=0.477, p<0.001). 
Fig. 1. Number of patients in each interventricular delay (VV) interval determined by echocardiography (ECHO) and intracardiac electrogram method (IEGM).
Fig. 2. Correlation between optimal interventricular delay (VV) determined by echocardiography and intracardiac electrogram method (IEGM).
Discussion
Th is prospective clinical trial of AV/PV and VV delay programming is the fi rst one that compared manual IEGM based on St Jude's CRT (Quick Opt TM algorithm) pacemakers with standard echocardiography optimization method 1, 18, 23, 24 . Our study is the fi rst to show that manual IEGM can be used for VV optimization after CRT implantation, even for devices that do not have automated IEGM system. Previous studies have shown that IEGM is an accurate alternative to time-consuming echocardiography techniques for VV optimization 14, 18, [23] [24] [25] . St Jude's CRT devices have automated IEGM systems, which can accurately calculate AV and VV delay in one minute. However, Medtronic CRT devices do not provide automated IEGM system and therefore, echocardiography techniques are the only possibility for AV and VV optimization. Our study showed that IEGM could be manually applied using caliper in patients implanted with Medtronic CRT devices. Correlation coeffi cient between echocardiographic and IEGM determined VV interval was somewhat lower than in previous studies (R=0.823) 1 , but VTIs were exactly the same when VV interval was estimated with echocardiography or IEGM [17.2 (6.8-25.6) vs. 17.2 (6.4-25.1), p=0.243]. Although manual IEGM takes a median of 20 (10-28) minutes, which is substantially longer when compared with automated IEGM, it is still less time-consuming than echocardiography [40 (35-60) minutes]. Th erefore, we can conclude that manual IEGM is a valuable option for AV and VV optimization. However, we suggest that automated IEGM system be implemented by all manufactures of CRT devices.
Th is study confi rmed the effi cacy of CRT in increasing EF of the left ventricle and decreasing both LVEDV and LVESV. Th ese changes were even greater than reported in previous studies, since we enrolled only patients with substantial QRS prolongation, who obviously gain substantial benefi t from CRT. Moreover, our study demonstrated that AV and VV optimization was necessary in patients undergoing CRT, and that further eff ort should be made in providing automated IEGM system by all CRT device manufacturers.
Th e main limitation of our study was the absence of long-term follow-up in patients undergoing CRT. Moreover, this was a non-randomized prospective study and thus, conclusions regarding diagnostic accuracy of manual IEGM should be interpreted with caution. However, our study provided a rationale for performing a randomized clinical trial that would compare long-term outcomes between patients in whom VV optimization performed with manual IEGM technique and by echocardiography.
In conclusion, our study indicated that manual IEGM could be good alternative to echocardiography and automated IEGM. It also emphasized the need for implementation of automated IEGM systems by all CRT device manufacturers in order to provide better understanding of conduction properties and optimal device programmed setting to get best cardiac function. Th e IEGM could also be an additional method providing faster ECHO optimization.
